SERPING1 and hereditary angioedema: C1-INH concentrates were originally used as intravenous on-demand treatment and short-term prophylaxis before performing invasive medical or dental procedures in patients with HAE to prevent acute attacks, but they have also been approved for use as long-term prophylaxis for subcutaneous regular replacement therapy.